Evidence map›Paper›PMID 40527917›Full record

ArticleNPJ digital medicine2025

Digital twin integrating clinical, morphological and hemodynamic data to identify stroke risk factors.

Marta Saiz-Vivó, Jordi Mill, Xavier Iriart, Hubert Cochet, Gemma Piella, Maxime Sermesant, Oscar Camara

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Left Atrial Appendage Occlusion in Cancer-Associated Atrial Fibrillation: Who, When, and How to Manage Antithrombotic Therapy.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta Saiz-VivóPhysense, BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain. marta.saiz@upf.edu.
Jordi MillPhysense, BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain.
Xavier IriartIHU Lyric, CHU Bordeaux, Université Bordeaux, Inserm, Pessac, France.
Hubert CochetIHU Lyric, CHU Bordeaux, Université Bordeaux, Inserm, Pessac, France.
Gemma PiellaPhysense, BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain.
Maxime SermesantInria, Université Côte d'Azur, Epione team, Sophia Antipolis, France.
Oscar CamaraPhysense, BCN MedTech, Department of Engineering, Universitat Pompeu Fabra, Barcelona, Spain.

Funding

European Union's Horizon 2020 research and innovation program 101016496Spanish Ministry of Science, Innovation and Universities PID2022-143239OB-I00
6 · The paper itself

Abstract

Stroke remains a leading global cause of mortality, with ischemic stroke as the most common subtype. Atrial fibrillation (AF) increases ischemic stroke risk due to thrombus formation in the left atrium (LA), particularly in the left atrial appendage (LAA). Traditional risk assessments, like the CHA

Identifiers

PMID40527917
PMCPMC12174328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.